Regulation & law · 06/03/1996Updated: 10/18/2026 · 1 min read

AML Corporation, d/b/a G & O Pharmacy, Faces Revocation of Registration

Summary

AML Corporation, operating as G & O Pharmacy, is facing the revocation of its registration, a move that could impact the pharmacy's operations and customer services.

Original source language: Federal Register — Justice DepartmentOpen original release →

Add your company to Business Communicator

We monitor business sources and connect attention with companies, profiles and services available in Business Communicator.

Create a free company profile Explore businesses on Business Maps →

Create a free company profile →

Explore insights

Business insights →

Global Markets News Trade Regulation News Business Technology News Fintech for Business: Payments & Banking News Supply Chain News Central Bank Policy News

Related business signals

Regulation & law · 9/8/2026

AndersonBrecon, Inc DBA PCI Pharma Services Seeks Registration as Controlled Substance Importer

AndersonBrecon, Inc DBA PCI Pharma Services has submitted an application to the government to be registered as an importer of controlled substances, a move that could impact the pharmaceutical industry.

Read summary →

Regulation & law · 9/8/2026

Fisher Clinical Services, Inc. Seeks Registration as Controlled Substance Importer

Fisher Clinical Services, Inc. has submitted an application to the U.S. government to be registered as an importer of controlled substances, a move that could potentially impact the pharmaceutical industry.

Read summary →

Regulation & law · 9/14/2026

Irvine Labs, Inc. Applies for Controlled Substances Importer Registration

Irvine Labs, Inc. has submitted a request to the government to be registered as an importer of controlled substances, a move that could impact the pharmaceutical industry.

Read summary →

Regulation & law · 9/8/2026

Cambrex High Point, Inc. Seeks Registration as Controlled Substance Importer

Cambrex High Point, Inc. has submitted a request to the government to be registered as an importer of controlled substances, a move that could impact the pharmaceutical industry.

Read summary →

Regulation & law · 9/11/2026

FBI Requests OMB Approval for Collection of Arrest Data on Minors

The FBI is seeking OMB approval to extend a previously approved data collection on the age, sex, race, and ethnicity of minors arrested under 18, as part of its Criminal Justice Information Services Division within the Department of Justice.

Read summary →

Regulation & law · 9/8/2026

Fresenius Kabi USA, LLC Seeks Registration as Controlled Substance Importer

Fresenius Kabi USA, LLC has submitted an application to the U.S. government to be registered as an importer of controlled substances, including basic classes of medications. The company aims to import these controlled substances for distribution in the United States.

Read summary →